17 Feb 2026 NOUV stock at $0.0001 on 675,000 volume: watch liquidity and risks

NOUV stock traded at $0.0001 on 17 Feb 2026 during market hours on the PNK exchange in the United States. The move came on volume of 675,000 shares, well above the average of 388,134. Nouveau Life Pharmaceuticals, Inc. (NOUV) shows a market cap near $90,000 and a year high of $0.0002, highlighting extreme microcap volatility for traders and speculators.

NOUV stock price and volume drivers

Nouveau Life Pharmaceuticals, Inc. (NOUV) moved from a previous close of $0.0000 to $0.0001 today on PNK. The intraday range was narrow at $0.0001 low and $0.0001 high, but the large trade count pushed relative volume to 1.74. High relative volume with tiny nominal prices often reflects speculative flows, short-term liquidity trades, or transfer agent activity.

This price and volume action connects to the company’s tiny market cap of $90,000 and 900,000,000 shares outstanding. With liquidity this low, small dollar trades will swing percentage moves by hundreds to thousands of percent.

Company profile and recent news affecting NOUV stock

Nouveau Life Pharmaceuticals, Inc. is a development stage nutraceuticals company. The firm is incorporated in the United States and lists on PNK under the industry ‘Shell Companies.’

There are no formal earnings announcements or SEC filings cited in today’s tape. For broader market context, see recent region coverage from the Wall Street Journal source.

Financials and key metrics behind NOUV stock moves

NOUV reports no revenue per share and negative net income per share. Key ratios include a price to book of 2.11 and a negative PE of -38.70. The current ratio is 0.0051, signaling minimal working capital on the balance sheet.

Net cash per share is effectively 0.0000006 and enterprise value stands near $153,806. These metrics show a development-stage shell with limited operating liquidity and negative operating cash flow per share.

Technical and trading signals for NOUV stock

Momentum indicators are mixed. The RSI reads 55.74, and the CCI is 104.09, suggesting short-term strength. Average price levels show a 50-day average of $0.000075 and a 200-day average of $0.00007325.

Volume-based indicators show on-balance volume at -6,124,674, reflecting net outflow historically. For traders, the tiny tick size and wide spreads elevate execution risk and slippage.

Meyka AI rates NOUV with a score out of 100 and analyst view

Meyka AI rates NOUV with a score out of 100: 63.25 (Grade B, Suggestion: HOLD). This grade factors in S&P 500 comparison, sector and industry comparisons, financial growth, key metrics, forecasts, analyst consensus, and fundamental growth.

Third-party company ratings show a recent D+ score dated 12 Feb 2026, labeled Strong Sell on several DCF and ratio metrics. These conflicting signals point to high uncertainty. These grades are not guaranteed and we are not financial advisors.

Risks and opportunities for NOUV stock investors

Risk is material. NOUV operates in the ‘Shell Companies’ industry with minimal employees and no clear revenue stream. Key risks include poor liquidity, low current ratio, and the potential for dilution from share issuances.

Opportunities are speculative. The year high of $0.0002 shows possible upside in a thin market. Short-term traders may capture gains, but longer-term investors face significant execution and business model risk.

Final Thoughts

Key takeaways for NOUV stock: the share price sits at $0.0001 on the PNK exchange in the United States with 675,000 shares traded today. Market capitalization is about $90,000, and liquidity remains the dominant factor driving price moves. Financial ratios show weak fundamentals, with a price to book of 2.11 and a negative PE of -38.70. Meyka AI’s forecast model projects a 12-month reference target of $0.0002, implying an upside of 100.00% from the current price. Forecasts are model-based projections and not guarantees. Traders should weigh the speculative upside against liquidity constraints, dilution risk, and the company’s development-stage profile. For live quotes and a dedicated summary, see the NOUV stock page on Meyka AI NOUV stock page and background coverage source.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.